- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Senores Pharmaceuticals Limited — Updates, 26-08-2026: General Updates
26-08-2026 | 06:50 pm
26-08-2026 | 06:50 pm
Senores Pharma appointed a new CS & Compliance Officer and an Independent Director. The board approved an ESOS 2026 covering 4.72 Lakh options (subject to shareholder nod). Further, the company plans international expansion with new subsidiaries in Mexico (WOS) and Canada.
No comments yet. Be the first to comment!